Obesity phenotypes related to musculoskeletal disorders; a cross-sectional study from RaNCD cohort

Archives of Public Health - Tập 80 - Trang 1-8 - 2022
Sheno Karimi1, Yahya Pasdar2, Behrooz Hamzeh2, Azad Ayenehpour1, Fatemeh Heydarpour3, Farjam Goudarzi4
1Department of Nutritional Sciences, School of Nutritional Sciences and Food Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran
2Research Center for Environmental Determinants of Health (RCEDH), Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
3Social Development and Health Promotion Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
4Regenerative Medicine Research Center (RMRC), Kermanshah University of Medical Sciences, Kermanshah, Iran

Tóm tắt

This study was evaluated the association between obesity phenotypes and risk of lower torso musculoskeletal disorders including low back pain (LBP), low back stiffness (LBS), arthralgia, and joint stiffness in Ravansar non-communicable diseases (RaNCD) cohort study. In this cross-sectional study, 6940 adults were examined for the presence of lower torso musculoskeletal disorders by a physician. Obesity phenotypes including metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUO) were defined based on the International Diabetes Federation, as well as, body mass index > 30 kg/m2. Metabolically unhealthy non-obesity (MUNO) phenotype was considered as unhealthy metabolic without obesity. The prevalence of LBP, LBS, arthralgia, and joint stiffness in MHO, MUO, and MUNO were significantly higher than in healthy participants compared to obesity phenotypes. Logistic regression showed that MHO phenotype was significantly increased with risk of LBP (OR: 1.19, CI 95%: 1.01–1.41), LBS (OR: 1.44, CI 95%: 1.12–1.86), arthralgia (OR: 1.54, CI 95%: 1.33–1.78), and joint stiffness (OR: 1.84, CI 95%: 1.35–2.52). Moreover, MUO phenotype was positively associated with risk of LBS (OR: 1.46, CI 95%: 1.09–1.94) and arthralgia (OR: 1.66, CI 95%: 1.41–1.96). In addition, MUNO phenotype was associated with a higher risk of arthralgia (OR: 1.21, CI 95%: 1.06–1.37). All three phenotypes, MHO, MUO and MUNO were significantly increased the risk of arthralgia. However, MHO phenotype was significantly associated with a higher risk of all examined lower torso musculoskeletal disorders in the current study.

Tài liệu tham khảo

Luan HD, Hai NT, Xanh PT, Giang HT, Van Thuc P, Hong NM, et al. Musculoskeletal disorders: prevalence and associated factors among district hospital nurses in Haiphong, Vietnam. BioMed Res Int. 2018;2018. Nguyen TH, Hoang DL, Hoang TG, Pham MK, Bodin J, Dewitte JD, et al. Prevalence and characteristics of multisite musculoskeletal symptoms among district hospital nurses in Haiphong, Vietnam. BioMed Res Int. 2020;2020. van der Gaag WH, Roelofs PD, Enthoven WT, van Tulder MW, Koes BW. Non‐steroidal anti‐inflammatory drugs for acute low back pain. Cochrane Database Syst Rev. 2020;4(4):Cd013581. Tagliaferri SD, Miller CT, Owen PJ, Mitchell UH, Brisby H, Fitzgibbon B, et al. Domains of chronic low back pain and assessing treatment effectiveness: a clinical perspective. Pain Pract. 2020;20(2):211–25. LaxmaiahManchikanti M, Radomir KM. Low back pain and diagnostic lumbar facet joint nerve blocks: Assessment of prevalence, false-positive rates, and a philosophical paradigm shift from an acute to a chronic pain model. Pain Physician. 2020;23:519–29. Pasdar Y, Hamzeh B, Moradi S, Cheshmeh S, Najafi F, Moradinazar M, et al. Better muscle strength can decrease the risk of arthralgia and back & joint stiffness in Kurdish men; a cross-sectional study using data from RaNCD cohort study. BMC Musculoskelet Disord. 2020;21(1):1–8. Ruta S, Prado ES, Chichande JT, Ruta A, Salvatori F, Magri S, et al. EULAR definition of “arthralgia suspicious for progression to rheumatoid arthritis” in a large cohort of patients included in a program for rapid diagnosis: role of auto-antibodies and ultrasound. Clin Rheumatol. 2020;39(5):1-7. Li Y, Schoufour J, Wang DD, Dhana K, Pan A, Liu X, et al. Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study. bmj. 2020;368:1669. Higgins DM, Buta E, Heapy AA, Driscoll MA, Kerns RD, Masheb R, et al. The relationship between body mass index and pain intensity among veterans with musculoskeletal disorders: findings from the msd cohort study. Pain Med. 2020;21(10):2563–72. Herzog W. Reflections on obesity, exercise, and musculoskeletal health. J Sport Health Sci. 2020;9(2):108. Al-Abed A-AAA. Obesity-Linked Diseases (Comorbidities). Obesity and its Impact on Health: Springer; 2021. p. 97–116. Kim S, Chang Y, Yun KE, Jung H-S, Kim I, Hyun YY, et al. Metabolically healthy and unhealthy obesity phenotypes and risk of renal stone: a cohort study. Int J Obes. 2019;43(4):852–61. Blüher M. Metabolically healthy obesity. Endocr Rev. 2020;41(3):405–20. Tsatsoulis A, Paschou SA. Metabolically healthy obesity: criteria, epidemiology, controversies, and consequences. Curr Obes Rep. 2020;9(2):109–20. Liao C, Gao W, Cao W, Lv J, Yu C, Wang S, et al. Associations of metabolic/obesity phenotypes with insulin resistance and C-reactive protein: results from the cntr study. Diabetes Metabolic Syndrome Obesity. 2021;14:1141. Walsh TP, Arnold JB, Evans AM, Yaxley A, Damarell RA, Shanahan EM. The association between body fat and musculoskeletal pain: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2018;19(1):1–13. Pasdar Y, Najafi F, Moradinazar M, Shakiba E, Karim H, Hamzeh B, et al. Cohort profile: Ravansar Non-Communicable Disease cohort study the first cohort study: in a Kurdish population. Int j epidemiol. 2019;48(3):682–3. Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar A-A, Hekmatdoost A, et al. Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): rationale, objectives, and design. Am J Epidemiol. 2017;187(4):647–55. Alberti KGM, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366(9491):1059–62. Pasdar Y, Hamzeh B, Moradi S, Cheshmeh S, Najafi F, Moradinazar M, et al. Better muscle strength can decrease the risk of arthralgia and back &joint stiffness in Kurdish men; a cross-sectional study using data from RaNCD cohort study. BMC Musculoskeletal Disord. 2020;21(1):686. Mendonça CR, Noll M. High prevalence of musculoskeletal pain in individuals with severe obesity: sites, intensity, and associated factors. Korean J Pain. 2020;33(3):245. Tang D, Xiao X, Chen L, Kangzhu Y, Deng W, Yang S, et al. Association of dietary patterns with obesity and metabolically healthy obesity phenotype in Chinese population: a cross-sectional analysis of China Multi-Ethnic Cohort Study. Bri J Nutr. 2022;10:1–11. Blümel JE, Arteaga E, Mezones-Holguín E, Zúñiga MC, Witis S, Vallejo MS, et al. Obesity is associated with a higher prevalence of musculoskeletal pain in middle-aged women. Gynecol Endocrinol. 2017;33(5):378–82. Masruroh E, Setyadhani E. Obesity factors on the incidence of joint pain of elderly. Jurnal Ners dan Kebidanan (Journal of Ners and Midwifery). 2021;8(2):206–10. Lee SW, Van Dien C, Won SJ. Adipose tissue as pain generator in the lower back and lower extremity: application in musculoskeletal medicine. HCA Healthc J Med. 2020;1(5):2. Azim S, Nicholson J, Rebecchi MJ, Galbavy W, Feng T, Rizwan S, et al. Interleukin-6 and leptin levels are associated with preoperative pain severity in patients with osteoarthritis but not with acute pain after total knee arthroplasty. Knee. 2018;25(1):25–33. Segar AH, Fairbank JC, Urban J. Leptin and the intervertebral disc: A biochemical link exists between obesity, intervertebral disc degeneration and low back pain—an in vitro study in a bovine model. Eur Spine J. 2019;28(2):214–23. Niemantsverdriet E, van den Akker EB, Boeters DM, van den Eeden SJ, Geluk A, van der Helm-van AH. Gene expression identifies patients who develop inflammatory arthritis in a clinically suspect arthralgia cohort. Arthritis Res Ther. 2020;22(1):1–7. Kose R, Sargin G, Senturk T, Cildag S, Unubol M, Abas B, et al. The association between clinically suspect arthralgia and adipokines in obese patients. Acta reumatol port. 2018;43(4):284–90. Wang T, He C. Pro-inflammatory cytokines: The link between obesity and osteoarthritis. Cytokine Growth Factor Rev. 2018;44:38–50. Walrabenstein W, van der Leeden M, Weijs P, van Middendorp H, Wagenaar C, van Dongen JM, et al. The effect of a multidisciplinary lifestyle program for patients with rheumatoid arthritis, an increased risk for rheumatoid arthritis or with metabolic syndrome-associated osteoarthritis: the “Plants for Joints” randomized controlled trial protocol. Trials. 2021;22(1):1–11. Giraud C, Lambert C, Dutheil F, Pereira B, Soubrier M, Tournadre A. The relationship between weight status and metabolic syndrome in patients with rheumatoid arthritis and spondyloarthritis. Joint Bone Spine. 2021;88(1): 105059.